US court affirms bar on Roche anemia drug launch

Biotech drugmaker Amgen Inc. said a federal court has enforced a preliminary injunction barring Roche from launching an anemia drug that would compete against its products. (AP, 10/10/08)

Angiotech due to collect royalties on stent

Angiotech Pharmaceuticals said Friday its corporate partner Boston Scientific Corp. received approval for its Taxus Libert drug-coated stent, which had been delayed by federal regulators. (AP, 10/10/08)

Midday Glance: Biotechnology companies

Shares of some top biotechnology companies are down at noon: Amgen fell $3.95 or 7.9 percent, to $46.31. (AP, 10/10/08)

Early Glance: Biotechnology companies

Shares of some top biotechnology companies are mixed at 10 a.m.: Amgen fell $1.82 or 3.6 percent, to $48.45. (AP, 10/10/08)

Ahead of the Bell: Biogen Idec

Analysts on Friday brushed off Biogen Idec Inc.'s decision to abandon development of an experimental arthritis drug, saying it had not even been included in models for future revenue. (AP, 10/10/08)